Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team

Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced the appointment of Aaron Ondrey, as Chief Financial...

Related Keywords

Martin Wilson ,Aaron Ondrey ,Kinnari Patel ,Mark White ,Jonathan Schwartz ,Gaurav Shah ,Clinical Development ,Nasdaq ,Youtube ,Arena Pharmaceuticals ,Schwartz ,Alexion Pharmaceuticals ,Linkedin ,Rocket Pharmaceuticals Inc ,Regeneron Pharmaceuticals ,Additional Updates To Corporate Leadership Team ,Bristol Myers Squibb ,Rocket Pharmaceuticals Announces Appointment Of Aaron Ondrey ,Corporate Development ,Pharmaceuticals Announces Appointment ,Chief Financial Officer ,Additional Updates ,Corporate Leadership ,Mirati Therapeutics ,Chief Operating ,Chief Medical ,Gene Therapy Officer ,General Manager ,Commercial Affairs ,Medical Affairs ,Commercial Operations ,General Counsel ,Chief Corporate Officer ,Chief Executive Officer ,Rocket Pharmaceuticals ,Fanconi Anemia ,Leukocyte Adhesion Deficiency I ,Pyruvate Kinase Deficiency ,Danon Disease ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,